The lawsuit was filed by Juliette Boyd, a woman from Florida who was implanted with the Meridian® Vena Cava Filter in September 2012. She is represented by Ben C. Martin of the Law Offices of Ben C. Martin in Dallas, Texas.
She accuses C.R. Bard of negligence for selling a defective medical device, failing to warn about side effects, and concealing safety risks.
It took the FDA 10 years to issue a safety communication stating on May 6, 2014 that “the risk of having an IVC filter in place is expected to outweigh the benefits.” Later that year the FDA started a nine-month investigation and issued two Form “483” letters in which it identified various deficiencies and violations by Bard at its IVC-filters facilities.
US District Judge David G. Campbell has ordered that cases be heard together in In Re Bard IVC Filters Product Liability Litigation, MDL 2641, where at least 810 lawsuits are pending against C.R. Bard. Another 800 lawsuits are pending in a similar litigation against Cook Medical.
Meridian is a temporary filter that is implanted in the inferior vena cava (IVC). It catches blood clots before they travel to the lungs and cause a pulmonary embolism.
The Meridian is very similar to other IVC filters made by C.R. Bard — including the G2 and Recovery — which have been linked to a 12% fracture risk in recent studies.
The FDA now recommends removing temporary IVC filters within 29-54 days. The longer they remain implanted, the higher the risk of complications.
The case was consolidated in a Multi-District Litigation (MDL No. 2641)
The lawsuit was filed on August 19 in the U.S. District Court for Arizona, Case No. 2:16-CV-02791.